Insights

If the past three years have taught QuantuMDx anything, it would be to prepare for the unexpected. While it can be difficult to predict which infectious disease will emerge as ‘the next big thing’, surveillance tools map the occurrence and…

International Day of Women & Girls in Science supports full and equal access to and…

Human papillomavirus (HPV) is the leading cause of cervical cancer. In this short post, which…

NEWCASTLE UPON TYNE, UK 13 December, 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay, has been approved for sale in the UK under The Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations…